{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:14:18Z","timestamp":1780625658841,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2017YFD0500800"],"award-info":[{"award-number":["2017YFD0500800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012453","name":"China Agricultural Research System","doi-asserted-by":"crossref","award":["CARS-42-17"],"award-info":[{"award-number":["CARS-42-17"]}],"id":[{"id":"10.13039\/501100012453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pharmthera.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T13:45:11Z","timestamp":1525614311000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development"],"prefix":"10.1016","volume":"190","author":[{"given":"Shun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2018.05.004_bb0005","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.00649-07","article-title":"Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines","volume":"81","author":"Abe","year":"2007","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-017-0739-8","article-title":"Elbasvir\/Grazoprevir: A review in chronic HCV genotypes 1 and 4","volume":"77","author":"Al-Salama","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0015","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/JVI.02188-08","article-title":"NS5 of dengue virus mediates STAT2 binding and degradation","volume":"83","author":"Ashour","year":"2009","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/viro.2001.1001","article-title":"Evidence for the presence of two novel Pestivirus species","volume":"286","author":"Avalos-Ramirez","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0030","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/sj.onc.1203522","article-title":"Modulation of STAT signaling by STAT-interacting proteins","volume":"19","author":"Bao","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0035","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate","volume":"279","author":"Benarroch","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0040","article-title":"The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling","volume":"91","author":"Best","year":"2016","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0045","doi-asserted-by":"crossref","first-page":"12828","DOI":"10.1128\/JVI.79.20.12828-12839.2005","article-title":"Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist","volume":"79","author":"Best","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0050","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1038\/35017119","article-title":"Collective nomenclature for LAP proteins","volume":"2","author":"Bilder","year":"2000","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(95)00580-3","article-title":"Protein kinases\u2014structure and function","volume":"369","author":"Bossemeyer","year":"1991","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0065","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1073\/pnas.1522987113","article-title":"Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents","volume":"113","author":"Brai","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","article-title":"Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase","volume":"1","author":"Brecher","year":"2015","journal-title":"Acs Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0075","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/viro.2000.0220","article-title":"Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence","volume":"269","author":"Campbell","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0085","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Microbiology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","article-title":"Combination of \u03b1-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo","volume":"89","author":"Chang","year":"2011","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.antiviral.2012.12.012","article-title":"Selective inhibition of the West Nile virus methyltransferase by nucleoside analogs","volume":"97","author":"Chen","year":"2013","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0100","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2015.07.010","article-title":"The search for nucleoside\/nucleotide analog inhibitors of dengue virus","volume":"122","author":"Chen","year":"2015","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/jir.2013.0038","article-title":"Hepatitis C virus NS5A protein modulates IRF-7-mediated interferon-\u03b1 signaling","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Journal of Interferon & Cytokine Research the Official Journal of the International Society for Interferon & Cytokine Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-662-09889-9_3","article-title":"Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis","volume":"27","author":"Clemens","year":"2001","journal-title":"Progress in Molecular and Subcellular Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/jir.1997.17.503","article-title":"The double-stranded RNA-dependent protein kinase PKR: Structure and function","volume":"17","author":"Clemens","year":"1997","journal-title":"Journal of Interferon & Cytokine"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0125","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/cmdc.201300343","article-title":"Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity","volume":"8","author":"Coburn","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-3527(09)74002-3","article-title":"New insights into flavivirus nonstructural protein","volume":"74","author":"Davidson","year":"2009","journal-title":"Advances in Virus Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0135","first-page":"A21","article-title":"Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication","volume":"82","author":"Delang","year":"2011","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine analog NITD008 is a potent inhibitor of Zika virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0145","first-page":"422","article-title":"Hepatitis C and hepatocellular carcinoma","volume":"26","author":"Di","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1711.2003.01157.x","article-title":"Evasion of innate and adaptive immunity by flaviviruses","volume":"81","author":"Diamond","year":"2003","journal-title":"Immunology & Cell Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0155","doi-asserted-by":"crossref","first-page":"32586","DOI":"10.1074\/jbc.M110.129197","article-title":"Structural and functional analyses of a conserved hydrophobic pocket of flavivirus methyltransferase","volume":"285","author":"Dong","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2008.04.026","article-title":"Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2\u2032-O methylations of viral RNA cap","volume":"377","author":"Dong","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.15252\/embj.201696241","article-title":"The crystal structure of Zika virus NS5 reveals conserved drug targets","volume":"36","author":"Duan","year":"2017","journal-title":"EMBO Journal"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0170","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.3390\/v9040091","article-title":"Dengue virus non-structural protein 5","volume":"9","author":"EI Sahili","year":"2017","journal-title":"Virus"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region","volume":"96","author":"Enomoto","year":"1995","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/genetics\/158.1.123","article-title":"Minimum requirements for the function of eukaryotic translation initiation factor 2","volume":"158","author":"Erickson","year":"2001","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0195","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1073\/pnas.87.21.8555","article-title":"ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains","volume":"87","author":"Fu","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2016.09.013","article-title":"Innate immune escape by Dengue and West Nile viruses","volume":"20","author":"Gack","year":"2016","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0205","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","article-title":"Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation","volume":"18","author":"Gale","year":"1998","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0215","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika virus targets human STAT2 to inhibit type I interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0220","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JVI.79.3.1343-1350.2005","article-title":"West Nile virus inhibits the signal transduction pathway of alpha interferon","volume":"79","author":"Guo","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","article-title":"The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains","volume":"241","author":"Hanks","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0230","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.4049\/jimmunol.174.12.8163","article-title":"Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell","volume":"174","author":"Ho","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.biochem.74.082803.133347","article-title":"NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease","volume":"74","author":"Inohara","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0240","article-title":"The viral polymerase inhibitor 7-deaza-2\u2032-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Joanna","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0245","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.biochi.2013.07.030","article-title":"Small molecule modulators of eukaryotic initiation factor 2\u03b1 kinases, the key regulators of protein synthesis","volume":"95","author":"Joshi","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0250","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaci.2006.02.023","article-title":"Toll-like receptor function and signaling","volume":"117","author":"Kaisho","year":"2006","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"56","author":"Kawai","year":"2006","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1357-2725(98)00128-9","article-title":"Eukaryotic initiation factor eIF2","volume":"31","author":"Kimball","year":"1999","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0275","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/17460441.2016.1160887","article-title":"New developments in flavivirus drug discovery","volume":"11","author":"Kok","year":"2016","journal-title":"Expert Opinion on Drug Discover"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/v6020683","article-title":"Targeting host factors to treat West Nile and dengue viral infections","volume":"6","author":"Krishnan","year":"2014","journal-title":"Virus"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0285","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/JVI.00533-12","article-title":"Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling","volume":"86","author":"Kumthip","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0290","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1128\/JVI.01161-09","article-title":"The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling","volume":"84","author":"Laurent-Rolle","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0295","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Laurent-Rolle","year":"2014","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1359-6101(96)00054-8","article-title":"The house that Jak\/Stat built","volume":"8","author":"Levy","year":"1997","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005737","article-title":"Potent allosteric Dengue virus NS5 polymerase inhibitors: Mechanism of action and resistance profiling","volume":"12","author":"Lim","year":"2016","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0310","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3390\/v5122977","article-title":"West Nile virus drug discovery","volume":"5","author":"Lim","year":"2013","journal-title":"Virus"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0315","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0320","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: Progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0325","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/JVI.02714-05","article-title":"Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism","volume":"80","author":"Lin","year":"2006","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0330","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1128\/MCB.20.17.6342-6353.2000","article-title":"Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha\/beta interferon genes by interferon regulatory factors 3 and 7","volume":"20","author":"Lin","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0335","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1128\/JVI.78.17.9285-9294.2004","article-title":"Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection","volume":"78","author":"Lin","year":"2004","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0340","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.4049\/jimmunol.0902728","article-title":"Distinct antiviral roles for human 2\u2032,5\u2032-oligoadenylate synthetase family members against dengue virus infection","volume":"183","author":"Lin","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Advances in Virus Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0350","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.79.3.1934-1942.2005","article-title":"Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins","volume":"79","author":"Liu","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2015.06.007","article-title":"Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFN-\u03b1R1 surface expression","volume":"18","author":"Lubick","year":"2015","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0360","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","article-title":"Hepatitis C virus NS5A: Tales of a promiscuous protein","volume":"85","author":"Macdonald","year":"2004","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0365","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/605847","article-title":"Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation","volume":"200","author":"Mazzon","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0370","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0092-8674(90)90374-N","article-title":"Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon","volume":"62","author":"Meurs","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0380","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2009.03.001","article-title":"Flaviviral methyltransferase\/RNA interaction: Structural basis for enzyme inhibition","volume":"83","author":"Milani","year":"2009","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003265","article-title":"Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling","volume":"9","author":"Morrison","year":"2013","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0390","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00705-016-3199-7","article-title":"Genomic characterization of a bovine viral diarrhea virus subtype 1i in Brazil","volume":"162","author":"Mosena","year":"2016","journal-title":"Archives of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0395","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virusres.2014.03.013","article-title":"Role of pattern recognition receptors in flavivirus infections","volume":"185","author":"Nazmi","year":"2014","journal-title":"Virus Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0400","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1074\/jbc.M115.710731","article-title":"A conserved pocket in the Dengue virus polymerase identified through fragment-based screening","volume":"291","author":"Noble","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0405","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/JVI.00045-13","article-title":"Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor","volume":"87","author":"Noble","year":"2013","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (Beh111 strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0415","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1128\/JVI.02830-06","article-title":"Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain","volume":"81","author":"Park","year":"2007","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0420","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/JVI.02202-15","article-title":"Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway","volume":"90","author":"Pattabhi","year":"2015","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0425","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.510290438","article-title":"Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication","volume":"29","author":"Polyak","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2016.12.021","article-title":"Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2\u2032-modified nucleotide analogues","volume":"140","author":"Potisopon","year":"2017","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0435","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/v2102169","article-title":"Inhibitors of the hepatitis c virus RNA-dependent RNA polymerase NS5B","volume":"2","author":"Powdrill","year":"2010","journal-title":"Virus"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0440","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.01216-09","article-title":"Mechanism of hepatitis C virus RNA polymerase inhibition with dihydroxypyrimidines","volume":"54","author":"Powdrill","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2011.01.009","article-title":"New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B","volume":"90","author":"Rai","year":"2011","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0450","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0455","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1128\/JVI.00900-10","article-title":"Hepatitis C virus infection impairs IRF-7 translocation and alpha interferon synthesis in immortalized human hepatocytes","volume":"84","author":"Raychoudhuri","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0460","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.immuni.2005.03.004","article-title":"Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins","volume":"22","author":"Rogers","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0465","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-9525(02)02738-5","article-title":"The LAP family: A phylogenetic point of view","volume":"18","author":"Santoni","year":"2002","journal-title":"Trends in Genetics"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0470","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.gastro.2016.06.002","article-title":"Prevalence of resistance-associated substitutions in HCV NS5a, NS5b, or NS3 and outcomes of treatment with ledipasvir and sofosbuvir","volume":"151","author":"Sarrazin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0475","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0480","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","article-title":"An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors","volume":"19","author":"Shan","year":"2016","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0485","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Shizuo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0490","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK\u2013STAT signaling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0495","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1099\/jgv.0.000612","article-title":"Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family","volume":"97","author":"Smith","year":"2016","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0500","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: A review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0505","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.6b10399","article-title":"Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0510","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1099\/vir.0.19513-0","article-title":"Hepatitis C virus NS5A protein interacts with 2\u2032,5\u2032-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner","volume":"85","author":"Taguchi","year":"2004","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0515","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1462-5822.2006.00716.x","article-title":"Interferon signalling network in innate defence","volume":"8","author":"Takaoka","year":"2006","journal-title":"Cellular Microbiology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0520","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0525","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/MCB.18.5.2431","article-title":"Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor","volume":"18","author":"Tan","year":"1998","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0968-0004(93)80001-R","article-title":"A template for the protein kinase family","volume":"18","author":"Taylor","year":"1993","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0535","article-title":"Novel broad spectrum inhibitors targeting the flavivirus methyltransferase","volume":"10","author":"Thiel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0540","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.antiviral.2010.12.006","article-title":"Anthracene-based inhibitors of dengue virus NS2B-NS3 protease","volume":"89","author":"Tomlinson","year":"2011","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0545","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/acs.jproteome.6b00933","article-title":"Systems biology reveals NS4B-cyclophilin A interaction: A new target to inhibit YFV replication","volume":"16","author":"Vidotto","year":"2017","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0550","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1038\/srep32336","article-title":"TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein","volume":"6","author":"Wang","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0555","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1462-5822.2007.01076.x","article-title":"Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling","volume":"10","author":"Werme","year":"2008","journal-title":"Cell Microbiology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0560","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0565","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ebiom.2016.09.013","article-title":"Zika virus replicons for drug discovery","volume":"12","author":"Xie","year":"2016","journal-title":"eBioMedicine"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0570","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/AAC.02203-15","article-title":"Identification of a pyridoxine-derived small-molecule inhibitor targeting dengue virus RNA-dependent RNA polymerase","volume":"60","author":"Xu","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0575","first-page":"727","article-title":"Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors","volume":"72","author":"Xu","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0580","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.vaccine.2012.11.015","article-title":"Immune evasion strategies of flaviviruses","volume":"31","author":"Ye","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0585","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","article-title":"Discovery of potent non-nucleoside inhibitors of Dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design","volume":"59","author":"Yokokawa","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0590","first-page":"621","article-title":"Toll-like receptors and innate immunity","volume":"388","author":"Yuk","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2018.05.004_bb0595","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2015.01.010","article-title":"OASL-a new player in controlling antiviral innate immunity","volume":"12","author":"Zhu","year":"2015","journal-title":"Current Opinion in Virology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818300780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818300780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:24:50Z","timestamp":1661145890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725818300780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":119,"alternative-id":["S0163725818300780"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.05.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}